TERESA SANTOS: Open Payments
NPI 1295517506 · NOKOMIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,525 in 75 payments from 15 companies in 2025. Trend: 2023 $36 · 2024 $1,175 · 2025 $1,525
Food & beverage: $1,525
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $425 |
| Lilly USA, LLC | 10 | $289 |
| Amgen Inc. | 16 | $151 |
| Exact Sciences Corporation | 4 | $110 |
| PFIZER INC. | 5 | $109 |
| Astellas Pharma US Inc | 4 | $94 |
| Novo Nordisk Inc | 5 | $94 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: QULIPTA, VRAYLAR, ZEPBOUND, OTEZLA, Veozah, MOUNJARO, UBRELVY, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
